advantag
genet
divers
ensur
success
sexual
reproduct
evolut
placent
mammal
come
inher
dilemma
matern
immun
system
must
toler
exist
semiallogen
foetusplacenta
express
self
matern
nonself
patern
antigen
also
clear
prevent
matern
reject
foetu
sustain
success
pregnanc
potent
mechan
immun
regul
must
activ
suppress
cell
activ
function
gener
suppressor
regulatori
treg
cell
function
antigen
specif
manner
recent
advanc
demonstr
import
coordin
immun
respons
pathogen
detect
nonself
antigen
innat
immun
system
activ
suppress
adapt
immun
respons
regard
dendrit
cell
dc
essenti
link
coordin
immun
respons
health
pregnanc
placenta
also
appear
play
import
though
poorli
understood
role
promot
immunotoler
state
human
placenta
uniqu
amongst
tissu
highest
express
human
endogen
retrovirus
evolutionari
fossil
ancient
time
point
infect
germ
line
cell
ongo
high
level
express
placenta
impli
impart
evolutionari
advantag
host
natur
occur
placent
protein
encod
one
retrovirus
shown
fuse
human
cytotrophoblast
cell
promot
syncytialis
crucial
placent
format
recent
also
determin
human
releas
placenta
suppress
matern
immun
respons
demonstr
potenti
play
role
maternalfoet
toler
matern
immun
toler
may
come
cost
increas
suscept
infect
pregnant
women
greater
risk
infect
intracellular
bacteria
virus
emerg
new
pandem
strain
swine
influenza
herein
refer
recent
refocuss
attent
issu
pandem
women
die
pregnant
startl
statist
emphasis
pregnant
women
increas
risk
develop
infect
influenza
also
like
develop
sever
diseas
increas
mortal
morbid
also
observ
season
influenza
numer
studi
report
increas
rate
influenzainduc
respiratori
hospitalis
pregnant
compar
nonpregn
women
sever
comorbid
identifi
predispos
suscept
infect
pregnanc
intrigu
impart
temporari
suscept
matern
immun
system
infect
understand
phenomenon
particular
note
pregnant
women
sever
infect
present
acut
syndrom
sever
respiratori
compromis
system
inflamm
associ
aberr
immun
respons
characteris
intens
acut
inflamm
increas
level
cytokin
also
reduc
antivir
thelper
th
respons
reduc
heighten
suppressor
cell
signal
implic
observ
develop
matern
state
immun
toler
may
particularli
impair
immun
respons
novel
pathogen
explain
suscept
pregnant
women
influenza
hypothesis
human
endogen
retrovir
envelop
protein
suppress
matern
cell
mediat
immun
respons
influenza
virus
impair
antivir
dc
promot
develop
suppressor
treg
cell
inhibit
develop
robust
antivir
immun
respons
assess
innat
respons
viru
recruit
women
never
vaccin
twelv
pregnant
women
nonvaccin
pnv
healthi
nonpregn
women
nonvaccin
npnv
recruit
octob
particip
studi
pregnant
women
recruit
john
hunter
hospit
jhh
antenat
clinic
nonpregn
women
recruit
advertis
inclus
criteria
particip
femal
childbear
age
year
pregnant
women
recruit
trimest
women
exclud
concomit
chronic
medic
ill
drug
alcohol
depend
current
smoke
asthma
respiratori
condit
coldflu
symptom
within
four
week
prior
sampl
collect
written
inform
consent
obtain
particip
prior
sampl
collect
ethic
approv
obtain
hunter
new
england
human
research
ethic
committe
univers
newcastl
research
ethic
committe
pregnant
nonpregn
women
attend
singl
studi
visit
baselin
characteris
assess
venepunctur
perform
strain
pandem
swine
flu
obtain
world
health
organ
melbourn
viral
stock
propag
madindarbi
canin
kidney
mdck
cell
atcc
manassa
va
usa
previous
describ
stock
viral
concentr
measur
use
plaqu
assay
determin
live
virion
base
plaqu
form
unit
per
ml
pfuml
ultraviolet
uv
inactiv
live
virus
achiev
place
live
virus
directli
uv
lamp
success
inactiv
confirm
plaqu
assay
recombin
ectodomain
protein
produc
purifi
follow
previous
state
method
recombin
ectodomain
clone
vector
novagen
use
restrict
enzym
scale
product
protein
express
e
coli
cell
stratagen
l
luria
broth
cultur
media
sigma
express
induc
iptg
sigma
protein
extract
solubl
cytoplasm
materi
use
bugbust
master
mix
merck
millipor
novagen
clarifi
supernat
purifi
twice
nickelcoupl
hitrap
imac
hp
column
three
hitrap
imac
hp
ml
column
ge
connect
seri
concentr
buffer
exchang
use
amicon
ultra
centrifug
filter
millipor
protein
prepurifi
prepar
sephadex
sigmaaldrich
x
cm
column
econocolumn
biorad
flow
rate
mlmin
bioactiv
oligomer
fraction
purifi
analyt
sephadex
x
cm
column
econocolumn
biorad
flow
rate
mlmin
mm
hepe
mm
nacl
protein
concentr
use
amicon
ultra
centrifug
filter
millipor
filter
steril
ensur
endotoxin
present
prepar
stock
test
use
limulu
amebocyt
lysat
lal
kit
lonza
follow
manufactur
instruct
protein
stock
store
concentr
mm
hepe
mm
nacl
work
solut
prepar
dilut
volum
stock
volum
buffer
mm
hepe
mm
nacl
fifti
syncytin
work
solut
ad
form
final
concentr
pbmc
isol
whole
blood
densiti
centrifug
use
ficollpaqu
plu
ge
healthcar
uppsala
sweden
resuspend
roswel
park
memori
institut
media
rpmi
invitrogen
australia
pti
limit
foetal
bovin
serum
fb
safc
bioscienc
lenexa
kansa
usa
pbmc
cultur
well
plate
final
concentr
cellsml
nunc
denmark
cell
stimul
viru
stimul
cell
stimul
moi
cultur
media
alon
concentr
base
abil
viru
induc
maxim
ifn
product
minim
cell
death
fig
cultur
cellular
suspens
centrifug
min
cell
lysat
store
buffer
rlt
qiagen
pti
ltd
doncast
vic
supernat
store
subsequ
analysi
protein
measur
cultur
supernat
elisa
follow
manufactur
instruct
r
system
mn
usa
analysi
use
fluorostar
optima
micropl
reader
bmg
labtech
ortenberg
germani
measur
cultur
supernat
use
cba
bd
bioscienc
ca
usa
sampl
run
bd
fac
canto
ii
flow
cytomet
analys
bd
fcap
array
softwar
bd
bioscienc
ca
usa
accord
manufactur
instruct
two
flow
cytometri
panel
use
dc
lymphocyt
panel
panel
subdivid
cytokin
measur
identifi
cell
releas
cytokin
well
marker
cell
activ
fluorochromeconjug
antibodi
use
dc
cytokin
panel
fixabl
viabil
stain
hladr
pe
fitc
antibodi
use
dc
activ
marker
panel
fixabl
viabil
stain
pe
hladr
apc
hlaa
b
c
fitc
antibodi
use
lymphocyt
cytokin
panel
fixabl
viabil
stain
pe
apc
fitc
antibodi
use
lymphocyt
activ
marker
panel
fixabl
viabil
stain
pe
apc
gitr
bd
bioscienc
ca
usa
except
gitr
ebiosci
usa
appropri
control
use
experi
elucid
cell
type
produc
cytokin
interest
addit
intracellular
cytokin
stain
perform
cell
two
n
non
pregnant
vaccin
women
sampl
run
bd
fac
aria
flow
cytomet
flowjo
softwar
tree
star
inc
usa
gate
strategi
exclud
doublet
cell
clump
dead
cell
intracellular
surfac
marker
stain
base
instruct
bd
bioscienc
doublet
cell
clump
exclud
time
gate
pbmc
popul
creat
scatter
plot
fsch
vs
fsca
fsca
vs
fscw
ssca
vs
fsca
neg
cell
popul
fell
within
four
plot
consid
singl
cell
viabl
pbmc
popul
total
event
collect
within
intersect
gate
isol
pbmc
first
cultur
ad
dilut
protein
blocker
brefeldin
bd
bioscienc
ca
usa
cultur
hour
total
hour
pbmc
centrifug
minut
resuspend
pb
buffer
final
concentr
pbmc
fixabl
viabil
stain
protocol
perform
accord
manufactur
instruct
pbmc
stain
either
dc
panel
lymphocyt
panel
cytokin
activ
marker
dc
panel
employ
follow
bd
bioscienc
cytofixcytoperm
manufactur
instruct
pbmc
stain
pdc
mdc
pbmc
also
stain
exclud
monocyt
b
cell
respect
determin
dc
popul
within
live
singl
cell
pbmc
popul
b
cell
monocyt
first
exclud
done
construct
scatter
plot
vs
lymphocyt
gate
popul
exclud
basophil
nk
cell
hladr
vs
plot
creat
dc
consid
hladr
posit
hladr
posit
cell
mdc
cell
consid
popul
whilst
pdc
consid
vs
scatter
plot
intracellular
cytokin
express
dc
popul
determin
plot
measur
percentag
posit
cell
parent
popul
lymphocyt
panel
employ
follow
bd
bioscienc
transcript
factor
buffer
set
manufactur
instruct
pbmc
stain
helper
cell
cytotox
cell
nk
cell
regulatori
cell
determin
cell
popul
within
live
singl
cell
pbmc
popul
scatter
plot
vs
creat
lymphocyt
gate
popul
helper
cell
consid
popul
whilst
cytotox
cell
consid
vs
scatter
plot
cell
place
vs
scatter
plot
regulatori
cell
consid
nk
cell
gate
cytokin
express
lymphocyt
popul
determin
plot
measur
percentag
posit
cell
parent
popul
dc
panel
measur
activ
marker
express
pdc
mdc
pbmc
stain
antibodi
hladr
hlaa
b
c
follow
incub
minut
pbmc
wash
twice
flow
stain
buffer
centrifug
resuspend
final
volum
flow
stain
buffer
gate
strategi
follow
howev
case
determin
percentag
pdcsmdc
posit
hladr
hlaa
b
c
scatter
plot
construct
marker
pdc
mdc
popul
gate
parent
popul
mean
fluoresc
intens
also
measur
activ
marker
lymphocyt
panel
measur
activ
marker
express
lymphocyt
pbmc
stain
antibodi
gitr
lymphocyt
panel
use
follow
bd
bioscienc
transcript
factor
buffer
set
manufactur
instruct
gate
strategi
follow
howev
case
determin
percentag
cell
posit
gitr
scatter
plot
construct
marker
treg
nk
cell
popul
gate
parent
popul
mean
fluoresc
intens
also
measur
activ
marker
data
express
mean
standard
error
mean
sem
twelv
subject
n
two
replic
subject
pregnant
women
ten
subject
n
two
replic
subject
nonpregn
women
except
flow
cytometri
analysi
carri
n
non
pregnant
women
statist
signific
assess
oneway
analysi
varianc
anova
posthoc
analysi
perform
use
holmsidak
correct
use
graphpad
prism
softwar
p
valu
consid
signific
npnv
compar
media
alon
pnv
also
npnv
syncytin
alon
compar
media
comparison
made
npnv
pnv
also
pnv
compar
media
alon
pbmc
pregnant
nonpregn
women
cultur
strain
influenza
isol
swine
flu
pandem
cultur
media
pbmc
nonpregn
women
demonstr
robust
pgml
ci
pgml
pgml
ci
pgml
respons
fig
compar
media
alon
exposur
convers
pbmc
pregnant
women
follow
stimul
produc
significantli
less
fig
ci
pgml
fig
pgml
ci
pgml
compar
pbmc
nonpregn
women
p
p
respect
howev
case
pgml
ci
pgml
fig
pbmc
nonpregn
women
pretreat
cultur
media
dose
select
perform
dose
respons
rang
biolog
relev
dose
abil
reduc
induc
ac
fig
cytotox
also
previous
measur
confirm
effect
cell
viabil
cytokin
releas
furthermor
prepar
techniqu
result
endotoxin
final
protein
use
size
exclus
chromatographi
abl
separ
two
major
peak
one
correspond
low
level
oligomer
anoth
multimer
complex
multimer
peak
correspond
bioactiv
conform
protein
use
experi
low
level
oligomer
peak
also
use
found
bioactiv
addit
significantli
reduc
pgml
ci
pgml
respons
pgml
ci
pgml
p
fig
fact
treatment
induc
respons
cell
mirror
seen
pbmc
pregnant
women
infect
alon
pnv
fig
infect
alon
induc
respons
either
pregnant
nonpregn
pbmc
compar
media
fig
pgml
ci
pgml
howev
substanti
increas
nonpregn
pbmc
pretreat
p
pgml
ci
pgml
use
flow
cytometri
surfac
stain
identifi
cell
respons
observ
respons
dc
lineag
identifi
pbmc
characteris
plasmacytoid
dc
pdc
myeloid
dc
mdc
fig
intracellular
cytokin
stain
pdc
popul
show
pdc
respons
releas
pdc
increas
percentag
posit
cell
presenc
compar
media
fig
panel
addit
reduc
pdc
express
fig
panel
furthermor
intracellular
cytokin
stain
lymphocyt
show
popul
respons
releas
percentag
posit
cell
reduc
presenc
fig
though
earli
timepoint
assess
releas
small
intracellular
cytokin
stain
pdc
popul
also
show
cell
respons
increas
releas
presenc
compar
media
fig
panel
combin
increas
pdc
express
fig
panel
although
major
pdc
also
small
amount
express
treg
cell
fig
confirm
pdc
activ
surfac
express
hladr
measur
infect
increas
express
hladr
fig
express
amplifi
pretreat
infect
alon
induc
releas
pbmc
either
pregnant
nonpregn
women
compar
media
howev
substanti
increas
nonpregn
pbmc
pretreat
p
fig
pgml
ci
pgml
also
exagger
releas
nonpregn
pbmc
pretreat
p
fig
pgml
ci
pgml
respons
significantli
elev
compar
seen
pregnant
pbmc
infect
alon
p
pgml
ci
pgml
pgml
ci
pgml
respect
impair
immun
respons
intracellular
pathogen
influenza
repres
ongo
import
risk
otherwis
healthi
pregnant
women
first
time
demonstr
placent
deriv
protein
impair
earli
innat
immun
respons
influenza
exposur
pbmc
npnv
women
result
robust
antivir
respons
characteris
releas
howev
respons
consider
reduc
pbmc
pnv
women
furthermor
exposur
pbmc
npnv
women
remark
alter
normal
antivir
respons
impair
releas
promot
releas
well
proinflammatori
cytokin
went
demonstr
earli
antivir
respons
predominantli
mediat
pdc
confirm
previou
data
impair
earli
innat
immun
respons
influenza
pregnanc
demonstr
induc
exposur
pdc
sequenc
retrovir
origin
make
substanti
part
mammalian
genom
analysi
human
genom
reveal
around
human
dna
deriv
retroviruslik
element
human
endogen
retrovirus
herv
deriv
exogen
retrovirus
ancient
timepoint
infect
germlin
cell
therefor
pass
human
cell
herv
envelop
gene
belong
hervw
famili
encod
protein
express
syncytiotrophoblast
first
describ
denot
shown
fuse
human
cytotrophoblast
cell
may
key
factor
regul
syncyti
placent
format
addit
fusogen
properti
role
syncyti
presenc
immunosuppress
region
isd
amino
acid
sequenc
also
identifi
normal
produc
secret
placenta
exosom
pregnanc
matern
plasma
exosom
protein
concentr
averag
mgml
plasma
first
second
third
trimest
respect
tm
subunit
carri
isd
placent
exosom
total
exosom
protein
mean
second
third
trimest
concentr
bioactiv
tm
matern
plasma
around
respect
therefor
use
recombin
ectodomain
within
expect
concentr
found
circul
placent
exosom
matern
blood
potenti
interact
matern
immun
system
sought
establish
whether
human
could
impair
matern
immun
respons
firstli
identifi
exosom
isol
placent
explant
tissu
matern
blood
contain
determin
isol
modifi
matern
immun
respons
inhibit
releas
tumour
necrosi
interferon
ifn
whole
blood
follow
invitro
stimul
lipopolysaccharid
presenc
placent
exosom
provid
mean
reach
interact
matern
immun
cell
repres
novel
mechan
endogen
retrovir
mediat
immunosuppress
may
relev
immun
toler
undesir
increas
suscept
infect
dendrit
cell
key
regul
immun
respons
promot
suppress
tcell
respons
depend
circumst
featur
dc
relat
abil
integr
divers
array
incom
signal
direct
appropri
adapt
tcell
immun
respons
import
role
dc
promot
matern
toler
pregnanc
recent
examin
pregnanc
progress
third
trimest
cell
undergo
chang
promot
state
reduc
respons
monocyt
pregnant
women
found
differenti
less
phenotyp
matur
dc
express
lower
level
hladr
molecul
compar
nonpregn
women
respons
inflammatori
stimuli
monocytederiv
dc
pregnant
women
upregul
secret
less
compar
cell
nonpregn
control
impli
dc
pregnant
women
reduc
abil
stimul
immun
respons
skew
toward
like
respons
less
capabl
protect
viral
infect
furthermor
factor
releas
trophoblast
invitro
also
shown
regul
innat
immun
respons
mous
dc
natur
killer
nk
cell
consist
also
shown
impair
innat
immun
respons
influenza
pregnant
women
pdc
pbmc
percentag
lower
pregnant
compar
nonpregn
women
p
follow
infect
pdc
pregnant
women
show
higher
express
p
hladr
p
neg
regul
p
compar
nonpregn
women
pbmc
also
demonstr
reduc
releas
respons
also
reduc
cell
mediat
immun
increas
express
cell
current
find
demonstr
exposur
pbmc
specif
impair
earli
innat
immun
respons
reduc
releas
ifn
pdc
mous
model
influenza
clearli
demonstr
pdc
recruit
lung
earli
influenza
infect
import
sourc
earli
also
regul
earli
robust
antivir
cell
respons
use
pdc
defici
mous
immun
respons
viru
delay
effect
cell
specif
respons
still
occur
allow
effect
viral
clearanc
therefor
case
pregnanc
impair
pdc
respons
may
enough
alon
explain
suscept
seen
pregnant
women
influenza
case
influenza
infect
anim
model
show
clearanc
infect
requir
robust
immun
respons
viru
optim
respons
consist
virusspecif
cell
cytotox
cell
lyse
virusinfect
cell
assess
earli
immun
respons
pbmc
influenza
model
respons
consequ
hour
time
point
predomin
pdc
small
number
cell
respons
releas
respons
influenza
trend
reduc
releas
optim
activ
cell
like
requir
longer
incub
period
influenza
pregnancyassoci
suscept
intracellular
pathogen
classic
attribut
shift
helper
cell
differenti
respons
requir
maintain
pregnanc
recent
work
shown
requir
expand
immun
toler
pregnanc
specif
link
expans
matern
treg
cell
exampl
circul
matern
treg
expand
peak
midgest
level
percent
higher
compar
nonpregn
state
recent
treg
activ
subsequ
immunotoler
phenotyp
shown
regul
placenta
matern
treg
expans
requir
sustain
pregnanc
may
creat
natur
occur
defici
host
defenc
expans
immunesuppress
regulatori
cell
treg
occur
physiolog
pregnanc
experiment
induc
mice
previous
shown
caus
enhanc
suscept
listeria
salmonella
suscept
reduc
tregabl
importantli
sustain
expans
matern
treg
essenti
maintain
immun
toler
develop
fetu
even
partial
transient
ablat
cell
fractur
matern
toler
fetal
antigen
trigger
fetal
resorpt
show
exposur
pbmc
led
signific
releas
releas
predominantli
pdc
lesser
extent
treg
cell
increas
play
import
role
activ
maintain
treg
especi
local
tissu
treg
activ
differenti
occur
via
notch
depend
signal
exert
posit
autocrin
effect
treg
addit
well
describ
immunosuppress
effect
cell
induc
anergi
reduc
abil
releas
cytokin
data
show
abil
impair
earli
innat
antivir
respons
well
induct
robust
respons
requir
effici
clear
infect
howev
result
may
suffici
explain
enhanc
suscept
influenza
pregnanc
appear
also
play
sinist
role
acut
worsen
acut
inflammatori
respons
influenza
includ
infect
usual
caus
sever
infect
overal
case
fatal
rate
howev
small
number
individu
sever
affect
requir
hospitalis
admit
intens
care
unit
icu
usual
sever
pneumonia
system
inflamm
respons
seen
caus
acut
sever
viral
pneumonia
sar
highli
pathogen
avian
influenza
sever
case
evid
dysregul
immun
respons
characteris
sever
lung
immunopatholog
intens
releas
acut
inflammatori
cytokin
suggest
inabl
switch
initi
innat
immun
respons
effect
adapt
immun
respons
certain
influenza
virus
specif
induc
respons
mous
model
pandem
influenza
strain
show
intens
neutrophil
lung
infiltr
consequ
may
contain
viru
potenti
produc
sever
acut
lung
injuri
sever
similar
evid
exagger
acut
respons
lee
et
al
compar
hospitalis
sever
patient
individu
season
influenza
found
evid
hyperactiv
proinflammatori
respons
characteris
elev
suppress
adapt
respons
reduc
elev
addit
elev
independ
predictor
admiss
icu
correl
close
exvivo
cytokin
respons
pbmc
pregnant
mice
infect
develop
acut
increas
kc
mous
equival
associ
intens
neutrophil
infiltr
lung
lead
widespread
epitheli
damag
failur
repair
damag
tissu
addit
adapt
immun
respons
impair
increas
altern
activ
macrophag
differ
seen
cell
respons
pregnant
mice
higher
number
treg
cell
present
bronchial
alveolar
lavag
fluid
recent
shown
similar
pictur
occur
human
pregnanc
associ
found
lymphocyt
sera
cytokin
well
increas
virusinfect
women
also
pregnant
women
increas
nk
tcell
cytokin
chemokin
product
respons
influenza
viru
vitro
particularli
viru
without
signific
chang
nkcell
tcell
tcell
frequenc
result
suggest
respons
pregnant
women
may
due
treatment
pbmc
alon
suffici
increas
releas
small
increas
seen
follow
exposur
releas
impli
treatment
monocyt
suffici
trigger
inflammasom
activ
monocyt
synthesis
releas
inact
cytoplasm
precursor
cytoplasm
process
biolog
activ
form
respons
variou
proinflammatori
stimuli
includ
virus
cystein
proteas
influenza
infect
directli
activ
monocyt
macrophag
appear
requir
prime
anoth
proinflammatori
signal
optim
respons
seen
follow
infect
could
signal
pregnanc
presenc
may
impair
antivir
interferon
respons
monocyt
dc
also
lead
heighten
activ
inflammasom
exagger
system
inflammatori
respons
replic
seen
sever
infect
neg
impact
respons
could
consider
recent
evid
suggest
genet
variant
may
exert
substanti
impact
suscept
infect
retrovir
infect
often
induc
immunosuppress
human
anim
relat
highli
conserv
sequenc
within
retrovir
envelop
transmembran
subunit
protein
call
immunosuppress
domain
isd
experi
use
acid
synthet
peptid
dimer
consensu
isd
sequenc
induc
immunosuppress
vivo
vitro
lymphocyt
monocyt
macrophag
natur
killer
natur
killer
cell
includ
modul
immun
respons
shown
inhibit
cytokin
along
upregul
also
shown
recombin
transmembarn
protein
human
immunodefici
viru
synthet
peptid
isd
sequenc
upregul
express
doserespons
sequenc
specif
manner
human
pbmc
result
consist
pbmc
nonpregn
women
expos
endogen
retrovir
envelop
protein
result
respons
entir
consist
describ
retroviru
mediat
immunosuppress
studi
demonstr
pbmc
pregnant
women
exhibit
impair
earli
antivir
respons
influenza
show
first
time
respons
induc
pbmc
healthi
women
exposur
placent
deriv
protein
exposur
lead
mark
reduct
pdc
releas
influenza
also
stimul
enhanc
releas
potenti
impair
adapt
respons
well
enhanc
releas
potenti
worsen
system
inflamm
first
studi
identifi
direct
link
placent
deriv
protein
suppress
matern
immun
given
risk
pose
season
pandem
influenza
well
intracellular
pathogen
pregnant
women
import
step
forward
potenti
identifi
target
could
manipul
improv
matern
fetal
outcom
global
futur
pandem
